Product Information
VOQUEZNA DUAL PAK is a brand product labeled by Phathom Pharmaceuticals Inc., priced at $7.4988 per EA under NDC 81520025014. Its NADAC has been published 89 times since Jan 22, 2025.
FDA first approved this application on May 3, 2022.
Manufacturer
Phathom Pharmaceuticals Inc.NDC
81520025014
Classification
Brand
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
New Drug (NDA)
FDA Application
NDA215153FDA Approved
5/3/2022
On Market Since
11/8/2023
Price Statistics
The NADAC for VOQUEZNA DUAL PAK has been published 89 times since Jan 22, 2025, and over the history we have for it it has risen 2.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.4988 per EA |
|---|---|
| All-time high | $7.5295 (May 13, 2026) |
| All-time low | $7.3036 (Jan 22, 2025) |
| 52-week high | $7.5295 |
| 52-week low | $7.3036 |
| Median price | $7.3102 |
| Average price | $7.3946 |
| Largest weekly change | +3.0% (Jan 7, 2026) |
| Weeks tracked | 89 |
| Tracking since | Jan 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the vonoprazan fumarate and amoxicillin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Phathom Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
vonoprazan fumarate and amoxicillin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VOQUEZNA DUAL PAK?
The current National Average Drug Acquisition Cost (NADAC) for VOQUEZNA DUAL PAK, manufactured by Phathom Pharmaceuticals Inc., is $7.4988 per EA (NDC 81520025014), effective Sep 30, 2026.
How has the price of VOQUEZNA DUAL PAK changed over time?
Over the history we have for it, the NADAC for VOQUEZNA DUAL PAK has risen 2.7%. It has been tracked across 89 weekly CMS publications since Jan 22, 2025.
What are the highest and lowest recorded NADAC prices for VOQUEZNA DUAL PAK?
Since Jan 22, 2025, the NADAC for VOQUEZNA DUAL PAK has ranged from a low of $7.3036 (Jan 22, 2025) to a high of $7.5295 (May 13, 2026), with a median of $7.3102 per EA.
Are there cheaper alternatives to VOQUEZNA DUAL PAK?
No other NADAC-published product currently shares the active ingredient and strength of VOQUEZNA DUAL PAK in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VOQUEZNA DUAL PAK?
VOQUEZNA DUAL PAK (NDC 81520025014) is labeled by Phathom Pharmaceuticals Inc., and CMS classifies it as a brand product.